Search research articles
Contact Us
Filters
Showing results (71-80 of 79) with videos related to
Page
of 8
Sort By:
You have reached the last page of results.
This site can display upto 79 results.
Chemosphere
|
January 16, 2007
Fish from industrially polluted freshwater as the main source of organochlorinated pollutants and increased frequency of thyroid disorders and dysglycemia
Pavel Langer, Anton Kocan, Mária Tajtaková, et al.
Chemosphere
|
August 19, 2007
Possible effects of persistent organochlorinated pollutants cocktail on thyroid hormone levels and pituitary-thyroid interrelations
Pavel Langer, Anton Kocan, Mária Tajtáková, et al.
RMD Open
|
October 21, 2022
Radiological evolution of spinal disease in alkaptonuria and the effect of nitisinone
Richard Imrich, Jana Sedláková, Mária Úlehlová, et al.
Cells
|
November 26, 2022
Effects of Nitisinone on Oxidative and Inflammatory Markers in Alkaptonuria: Results from SONIA1 and SONIA2 Studies
Daniela Braconi, Michela Geminiani, Eftychia Eirini Psarelli, et al.
Chemosphere
|
June 1, 2007
Thyroid ultrasound volume, structure and function after long-term high exposure of large population to polychlorinated biphenyls, pesticides and dioxin
Pavel Langer, Mária Tajtáková, Anton Kocan, et al.
Journal of Inherited Metabolic Disease
|
October 15, 2019
Homogentisic acid is not only eliminated by glomerular filtration and tubular secretion but also produced in the kidney in alkaptonuria
Lakshminarayan R Ranganath, Anna M Milan, Andrew T Hughes, et al.
European Journal of Human Genetics : EJHG
|
March 26, 2015
Twelve novel HGD gene variants identified in 99 alkaptonuria patients: focus on 'black bone disease' in Italy
Martina Nemethova, Jan Radvanszky, Ludevit Kadasi, et al.
Annals of the Rheumatic Diseases
|
December 6, 2014
Suitability Of Nitisinone In Alkaptonuria 1 (SONIA 1): an international, multicentre, randomised, open-label, no-treatment controlled, parallel-group, dose-response study to investigate the effect of once daily nitisinone on 24-h urinary homogentisic acid excretion in patients with alkaptonuria after 4 weeks of treatment
Lakshminarayan R Ranganath, Anna M Milan, Andrew T Hughes, et al.
The Lancet. Diabetes & Endocrinology
|
August 22, 2020
Efficacy and safety of once-daily nitisinone for patients with alkaptonuria (SONIA 2): an international, multicentre, open-label, randomised controlled trial
Lakshminarayan R Ranganath, Eftychia Eirini Psarelli, Jean-Baptiste Arnoux, et al.
Page
of 8
Search research articles
Search
Showing results (71-80 of 79) with videos related to
Sort By:
Page
of 8
You have reached the last page of results.
This site can display upto 79 results.
Chemosphere
|
January 16, 2007
Fish from industrially polluted freshwater as the main source of organochlorinated pollutants and increased frequency of thyroid disorders and dysglycemia
Pavel Langer, Anton Kocan, Mária Tajtaková, et al.
Chemosphere
|
August 19, 2007
Possible effects of persistent organochlorinated pollutants cocktail on thyroid hormone levels and pituitary-thyroid interrelations
Pavel Langer, Anton Kocan, Mária Tajtáková, et al.
RMD Open
|
October 21, 2022
Radiological evolution of spinal disease in alkaptonuria and the effect of nitisinone
Richard Imrich, Jana Sedláková, Mária Úlehlová, et al.
Cells
|
November 26, 2022
Effects of Nitisinone on Oxidative and Inflammatory Markers in Alkaptonuria: Results from SONIA1 and SONIA2 Studies
Daniela Braconi, Michela Geminiani, Eftychia Eirini Psarelli, et al.
Chemosphere
|
June 1, 2007
Thyroid ultrasound volume, structure and function after long-term high exposure of large population to polychlorinated biphenyls, pesticides and dioxin
Pavel Langer, Mária Tajtáková, Anton Kocan, et al.
Journal of Inherited Metabolic Disease
|
October 15, 2019
Homogentisic acid is not only eliminated by glomerular filtration and tubular secretion but also produced in the kidney in alkaptonuria
Lakshminarayan R Ranganath, Anna M Milan, Andrew T Hughes, et al.
European Journal of Human Genetics : EJHG
|
March 26, 2015
Twelve novel HGD gene variants identified in 99 alkaptonuria patients: focus on 'black bone disease' in Italy
Martina Nemethova, Jan Radvanszky, Ludevit Kadasi, et al.
Annals of the Rheumatic Diseases
|
December 6, 2014
Suitability Of Nitisinone In Alkaptonuria 1 (SONIA 1): an international, multicentre, randomised, open-label, no-treatment controlled, parallel-group, dose-response study to investigate the effect of once daily nitisinone on 24-h urinary homogentisic acid excretion in patients with alkaptonuria after 4 weeks of treatment
Lakshminarayan R Ranganath, Anna M Milan, Andrew T Hughes, et al.
The Lancet. Diabetes & Endocrinology
|
August 22, 2020
Efficacy and safety of once-daily nitisinone for patients with alkaptonuria (SONIA 2): an international, multicentre, open-label, randomised controlled trial
Lakshminarayan R Ranganath, Eftychia Eirini Psarelli, Jean-Baptiste Arnoux, et al.
Page
of 8